Erbitux
Showing 1 - 25 of 423
Head Neck Cancer Trial in Heidelberg (Erbitux®, Fractionated Radiotherapy)
Completed
- Head and Neck Cancer
- Erbitux®
- Fractionated Radiotherapy
-
Heidelberg, Baden-Württemberg, GermanyUniversity of Heidelberg Medical Center
May 18, 2022
Glioblastoma Multiforme, Anaplastic Astrocytoma, Fibrillary Astrocytomas Trial in Miami (SIACI of cetuximab and bevacizumab)
Not yet recruiting
- Glioblastoma Multiforme
- +4 more
- SIACI of cetuximab and bevacizumab
-
Miami, FloridaJackson Memorial Hospital
Jul 14, 2023
Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial
Recruiting
- Glioblastoma
- +8 more
- Intra-arterial Cetuximab
- +2 more
-
New York, New YorkLenox Hill Brain Tumor Center
Oct 17, 2022
Metastatic Colorectal Cancer Trial (Cetuximab and irinotecan)
Not yet recruiting
- Metastatic Colorectal Cancer
- Cetuximab and irinotecan
- (no location specified)
Jul 26, 2023
Carcinoma, Squamous Cell, Carcinoma, Squamous Cell of Head and Neck Trial in New York (Intraarterial Cetxuimab (Erbitux))
Terminated
- Carcinoma, Squamous Cell
- Carcinoma, Squamous Cell of Head and Neck
- Intraarterial Cetxuimab (Erbitux)
-
New York, New YorkLenox Hill Hospital
Oct 27, 2021
Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Trial (Monalizumab, Cetuximab)
Not yet recruiting
- Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
- Monalizumab
- Cetuximab
- (no location specified)
Jan 8, 2023
Head Neck, Squamous Cell Carcinoma of Head and Neck Trial in Houston (Pembrolizumab, Magrolimab, cetuximab)
Not yet recruiting
- Head Neck
- Squamous Cell Carcinoma of Head and Neck
- Pembrolizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Sep 14, 2023
Metastatic Colorectal Cancer Trial in Guangzhou (Cetuximab, Capecitabine)
Recruiting
- Metastatic Colorectal Cancer
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated Hospital of Sun Yat-sen University
Mar 7, 2023
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in
Not yet recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +2 more
- Cetuximab
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 2, 2023
Colon Cancer, Colorectal Cancer Trial in Houston (MRTX849, Irinotecan, Cetuximab)
Not yet recruiting
- Colon Cancer
- Colorectal Cancer
- MRTX849
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2023
Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial (Ficlatuzumab,
Not yet recruiting
- Metastatic Head-and-neck Squamous-cell Carcinoma
- Recurrent Head and Neck Squamous Cell Carcinoma
- Ficlatuzumab
- +2 more
- (no location specified)
Sep 26, 2023
Metastatic Colorectal Cancer Trial in Houston (Cetuximab, Ulixertinib, Encorafenib)
Not yet recruiting
- Metastatic Colorectal Cancer
- Cetuximab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 9, 2023
Barrett's Esophagus Without Dysplasia, Barrett Oesophagitis With Dysplasia, Esophageal Adenocarcinoma Trial in Groningen
Not yet recruiting
- Barrett's Esophagus Without Dysplasia
- +2 more
- Avastin
- +2 more
-
Groningen, NetherlandsUniversity Medical Center Groningen
Feb 24, 2023
Cancer of the Colon, Colon Cancer, Colon Tumors Trial in Chapel Hill (Cetuximab, Palbociclib)
Recruiting
- Cancer of the Colon
- +4 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Jan 25, 2022
Head Neck Cancer, Squamous Cell Carcinoma of the Head and Neck Trial in La Jolla (Ibrutinib 560mg PO daily (Imbruvica),
Active, not recruiting
- Head and Neck Cancer
- Squamous Cell Carcinoma of the Head and Neck
- Ibrutinib 560mg PO daily (Imbruvica)
- +2 more
-
La Jolla, CaliforniaUCSD Moores Cancer Center
Jan 11, 2023
Metastatic Colorectal Cancer Trial in Munich (Irinotecan, Folinic Acid, 5-FU)
Recruiting
- Metastatic Colorectal Cancer
- Irinotecan
- +8 more
-
Munich, GermanyKlinikum der Universitaet Muenchen - Campus Grosshadern
Dec 2, 2021
Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in France, United Kingdom, United States (NUC-3373 +
Recruiting
- Colorectal Cancer
- +4 more
- NUC-3373 + leucovorin
- +8 more
-
Boston, Massachusetts
- +9 more
Jan 23, 2023
Head Neck Cancer, Locally Advanced Trial in Bangkok (Palbociclib, Cetuximab, Intensity Modulated Radiation Therapy)
Active, not recruiting
- Head and Neck Cancer
- Locally Advanced
- Palbociclib
- +2 more
-
Bangkok, ThailandFaculty of Medicine, Ramathibodi Hospital
Sep 19, 2022
Colon Adenocarcinoma, Microsatellite Stable Colon Carcinoma, Stage IIB Colon Cancer AJCC v8 Trial (drug, biological, procedure,
Not yet recruiting
- Colon Adenocarcinoma
- +4 more
- Encorafenib
- +5 more
- (no location specified)
Jan 24, 2023